Articles

Mental health care providers are subject to unique constraints and incentives, compared to other specialists.

Requiring data on actual net costs will improve negotiations over the “maximum fair price” for select drugs under Medicare.

Leonard and Pamela Schaeffer’s $59 million gift establishes a new institute that will address multiple public policy issues with evidence-based research and educate new generations of scholars to help solve our nation’s policy challenges.

A new study by researchers at USC explains why kids aren’t getting a cheap, effective treatment for diarrhea.

The change to Medicare Advantage payments could incentivize improvements in dementia detection, but also raises concerns about inappropriate overdiagnosis.

Often under financial pressure while being asked to do more, hospitals and health systems need new approaches to ensure high-value care.

Schaeffer experts submitted a comment letter responding to a request for information from stakeholders about improving access to cell and gene therapies for ultra-rare diseases.

Letters notifying physicians of patient overdose deaths and providing a plan for the future is an effective intervention, according to new USC Schaeffer Center research

The IRA threatens to deliver disaster across the entire innovation, financing and distribution system for prescription drugs.

Lack of awareness remains one of the biggest barriers to participation in Alzheimer’s disease clinical trials, especially among underrepresented groups. New ways to connect with communities and to expand access to clinical trials include a virtual Alzheimer’s disease informational series, which reveals important insights about how people engage with virtual content differently than at in-person events.